SCHEMBL2010422

SCHEMBL2010422

CCOC(=O)COc1ccc(C(C)=O)cc1OCC(=O)OCC

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.66
ALDH1A1 P00352 3/20 0.53
CREBBP Q92793 1/20 0.53
NPSR1 Q6W5P4 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
HPGD P15428 1/20 0.48
CASP1 P29466 1/20 0.48
HSD17B10 Q99714 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ESR1 P03372 1/20 0.47
TSHR P16473 2/20 0.46
CASP3 P42574 1/20 0.46
CASP7 P55210 1/20 0.46
CASP9 P55211 1/20 0.46
USP2 O75604 1/20 0.46
MAPK1 P28482 1/20 0.45
PTPN1 P18031 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perchlorate SCHEMBL5784148 0.93 KMT2A (0.59) KMT2AALDH1A1CREBBPNPSR1KDM4E
SCHEMBL7465120 0.93 KMT2A (0.78) KMT2AALDH1A1CREBBPMEN1SMN1; SMN2
SCHEMBL6818308 0.92 KMT2A (0.61) KMT2AALDH1A1CREBBPNPSR1KDM4E
SCHEMBL2439155 0.89 KMT2A (0.57) KMT2AALDH1A1CREBBPNPSR1KDM4E
SCHEMBL2007531 0.87 ALDH1A1 (0.54) KMT2AALDH1A1CREBBPNPSR1KDM4E
SCHEMBL5531456 0.87 KMT2A (0.54) KMT2AALDH1A1CREBBPNPSR1KDM4E
SCHEMBL7361563 0.84 KMT2A (0.65) KMT2AALDH1A1CREBBPKDM4EMEN1
SCHEMBL2009931 0.84 ALDH1A1 (0.50) KMT2AALDH1A1NPSR1KDM4EMEN1
SCHEMBL2012694 0.84 ALDH1A1 (0.50) KMT2AALDH1A1NPSR1KDM4EMEN1
SCHEMBL29463757 0.83 CREBBP (0.72) KMT2AALDH1A1CREBBPNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964628-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-06-21 US disclosed
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-10-07 US disclosed
US-7759387-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-07-20 US disclosed
US-20070021489-A1 Fibrinogen receptor antagonists and their use NICHOLAS PIRAMAL INDIA LIMITED (IN) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE FGB, F13B, F2 KMT2A 4561/4885ALDH1A1 2548/4885CREBBP 3449/4885
US-20070021489-A1 Fibrinogen receptor antagonists and their use FGB, F13B, F2 KMT2A 4561/4885ALDH1A1 2548/4885CREBBP 3449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.